MYOSMake Your Own Software
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
2 July 2012 - Chardan Capital Markets LLC has been engaged as placement agent for the USD5.6m (EUR4.4m) stock sale of Myos Corp (OTC:MYOS), the US developer of nutritional supplements said on Monday.
Sometime after the University of Chicago had ended excavations in 1982, it was discovered that Quseir al-Qadim was probably not the minor port of Leucos Limen after all, but the important site of Myos Hormos.
These two tomes document several seasons of archaeological survey and excavation conducted by the IFAO along the ancient route linking the Roman, and likely Ptolemaic, port of Myos Hormos on the Red Sea coast of Egypt with the Nile emporium of Coptos.
Myos Rens Technology, "The Muscle Company," is focused on developing products that improve muscle health and performance, and bringing them to market.
Most recently, Mandel has served as a director of MYOS RENS from December 2015 until March 2016.
Through the end of 2016, DIL will manufacture and supply Fortetropin exclusively for MYOS, with a significant cost-savings component.
Biotherapeutics company MYOS Corporation (NASDAQ:MYOS) stated on Thursday that Health Canada has reviewed and approved its proprietary ingredient Fortetropin for sale in powder dose form in Canada.
Biotherapeutics company MYOS (NasdaqCM:MYOS) reported on Thursday the receipt of the US Patent and Trademark Office's (USPTO) Notice of Allowance from for US Patent Application Serial No.
MYOS, an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialisation of products that improve muscle health and performance, has signed a research and development contract with United States-based Cloud Pharmaceuticals.
Biotherapeutics company MYOS (NASDAQ:MYOS) reported on Wednesday that Douglas Weekes has been named as its chief commercial officer.
Human muscle health company MYOS Corporation (OTCBB:MYOS) said on Thursday that it has entered into an exclusive supply contract with Deutsches Institut fur Lebensmitteltechnik eV (DIL), the German Institute for Food Technologies.
Therapeutic products company MYOS Corporation (OTCBB:MYOS) reported on Tuesday the inclusion of the highly regarded MYO-T12 formulation in MYO-X at retail powerhouse GNC.